• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.

    8/12/25 5:09:40 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care
    Get the next $LUCY alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Innovative Eyewear, Inc.

    (Name of Issuer)


    Common stock, par value $0.00001 per share

    (Title of Class of Securities)


    45791D208

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    45791D208


    1Names of Reporting Persons

    Mitchell P. Kopin
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    475,728.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    475,728.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    475,728.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.99 %
    12Type of Reporting Person (See Instructions)

    HC, IN


    SCHEDULE 13G

    CUSIP No.
    45791D208


    1Names of Reporting Persons

    Daniel B. Asher
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED STATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    475,728.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    475,728.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    475,728.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.99 %
    12Type of Reporting Person (See Instructions)

    HC, IN


    SCHEDULE 13G

    CUSIP No.
    45791D208


    1Names of Reporting Persons

    Intracoastal Capital LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    475,728.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    475,728.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    475,728.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    9.99 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Innovative Eyewear, Inc.
    (b)Address of issuer's principal executive offices:

    11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
    (b)Address or principal business office or, if none, residence:

    The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
    (c)Citizenship:

    Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
    (d)Title of class of securities:

    Common stock, par value $0.00001 per share
    (e)CUSIP No.:

    45791D208
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    As of the close of business on June 30, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 475,728 shares of Common Stock, which consisted of (i) 288,282 shares of Common Stock held by Intracoastal and (ii) 187,446 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 4,574,602 shares of Common Stock outstanding as of June 30, 2025, as reported by the Issuer, plus (2)187,446 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1. The foregoing excludes (I) 1,910,400 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 because Intracoastal Warrant 1 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 102,698 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2") because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (III) 4,721 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3") because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (IV) 61,476 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4") because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (V) 61,476 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal ("Intracoastal Warrant 5") because Intracoastal Warrant 5 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 5 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 2,616,499 shares of Common Stock.
    (b)Percent of class:

    9.99%
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    475,728

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    475,728

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Mitchell P. Kopin
     
    Signature:/s/ Mitchell P. Kopin
    Name/Title:Mitchell P. Kopin
    Date:08/12/2025
     
    Daniel B. Asher
     
    Signature:/s/ Daniel B. Asher
    Name/Title:Daniel B. Asher
    Date:08/12/2025
     
    Intracoastal Capital LLC
     
    Signature:/s/ Mitchell P. Kopin
    Name/Title:Mitchell P. Kopin, Manager
    Date:08/12/2025
    Get the next $LUCY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LUCY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUCY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 4:12:34 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:41:40 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $2,649,148 worth of shares (297,443 units at $8.91) and sold $384,100 worth of shares (42,328 units at $9.07) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:40:55 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Innovative Eyewear Inc. Reports Q2 2025 Unaudited Financial Results

    Revenue Surged 88% in Q2 2025 vs. Q2 2024 MIAMI, Aug. 14, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer®, and Reebok® brands, today announced its unaudited financial results for the three and six months ended June 30, 2025. Net revenue for the quarter ended June 30, 2025 was $579,230, an increase of 88% from the quarter ended June 30, 2024. On a year-to-date basis, net revenue for the six months ended June 30, 2025 was $1,033,731, an increase of 49% from the comparable period in 2024.

    8/14/25 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Announces Participation in Key Industry and Investor Events in Q3 2025

    MIAMI, Aug. 11, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor™, Reebok®, Eddie Bauer® and Nautica® brands, today announces its participation in a series of key investor and industry focused events scheduled throughout the third quarter of 2025. Q3 2025 Scheduled Events Skyline Signature Series Webinar (Virtual; August 12): The Skyline Signature Series is a live virtual webinar that provides public companies with a convenient and effective forum to communicate their story to a diverse audienc

    8/11/25 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Launches Reebok Smartglasses in New Channels

    MIAMI, July 21, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor™, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce that its groundbreaking Reebok athletic smartglasses will be available today on the Reebok mobile app, to be followed by Reebok.com on August 1. The Reebok.com website is a go-to hub for athletic apparel and accessories, receiving approximately 570,000 monthly organic visitors.1 The Company believes this will be a key driver

    7/21/25 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gayle Oswald

    3 - Innovative Eyewear Inc (0001808377) (Issuer)

    10/25/24 9:59:55 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 4:12:34 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

    4/A - Innovative Eyewear Inc (0001808377) (Issuer)

    9/27/24 2:41:40 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    SEC Filings

    View All

    Innovative Eyewear Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Innovative Eyewear Inc (0001808377) (Filer)

    8/27/25 7:45:33 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    SEC Form 144 filed by Innovative Eyewear Inc.

    144 - Innovative Eyewear Inc (0001808377) (Subject)

    8/19/25 10:58:12 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Innovative Eyewear Inc (0001808377) (Filer)

    8/15/25 5:01:28 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Eyewear, Inc. Announces Exciting New Features for the Lucyd ChatGPT App

    MIAMI, May 29, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)), the manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Eddie Bauer® and Nautica® brands, is pleased to announce a powerful new update to the Company's Lucyd app for iOS and Android. The Lucyd app was the first to enable voice access to ChatGPT in smart eyewear, and the Company believes these latest enhancements further advance its market position as a leader in smart eyewear.   Below are the new updates: App Shopping. Both the iOS and

    5/29/25 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador

    MIAMI, Dec. 14, 2023 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer of the developer of ChatGPT smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce the signing of Emmanuel Ogbah as an official brand ambassador. Emmanuel Ikechukwu Ogbah is a Nigerian professional football defensive end for the Miami Dolphins. He played college football at Oklahoma State and was drafted by the Cleveland Browns in the second round of the 2016 NFL Draft. Lucyd eyewear's open-ear au

    12/14/23 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Financials

    Live finance-specific insights

    View All

    Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results

    Revenue Increased 14% in Q3 2024 vs Q3 2023, and 76% on a Year-to-Date Basis vs 2023 MIAMI, Nov. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the third quarter of 2024. Net revenue for the quarter ended September 30, 2024 was $253,599, an increase of 14% from the quarter ended September 30, 2023. This year-over-year increase was primarily attributable to strategic reductions in price discounts and other adjustments to o

    11/13/24 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan

    MIAMI, Sept. 25, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right ("Right") for each outstanding share of common stock. The record date for such dividend distribution is September 25, 2024. The Rights Plan expires, without any further action being required to be taken by Innovative Eyewear's Board of Directors, on September 25, 2025 or at such earlier time as disclos

    9/25/24 8:20:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results

    Quarterly Revenue Increased 82% vs Q2 2023; Gross Margin Increases Substantially MIAMI, Aug. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the second quarter of 2024. Net revenue for the quarter ended June 30, 2024 was $308,682, an increase of 82% from the quarter ended June 30, 2023. Net revenue for the six months ended June 30, 2024 was $692,153, an increase of 120% vs. the comparable period in 2023.

    8/13/24 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $LUCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Innovative Eyewear Inc.

    SC 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

    11/13/24 11:18:48 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

    SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

    10/4/24 4:43:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

    SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

    9/25/24 4:17:38 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care